Literature DB >> 18773298

Opioids and infections in the intensive care unit should clinicians and patients be concerned?

Craig R Weinert1, Shravan Kethireddy, Sabita Roy.   

Abstract

There is a large body of experimental evidence in research animals and in vitro models that opioids suppress the immune system. If this effect occurs in acute human disease, then patients cared for in Intensive Care Units (ICUs) would be a particularly vulnerable population. ICU patients have the most severe forms of acute infection, have the greatest risk of acquiring new infections in the hospital, and are exposed to high doses of opioids for long periods of time. We review the epidemiology of ICU infections and the pharmacoepidemiology of opioid use in critically ill patients. We critique the limited human research examining the relationship between opioids and infection and make recommendations on designing future clinical studies that could close the knowledge gap about the true hazards of opioid use in hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773298     DOI: 10.1007/s11481-008-9124-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  108 in total

1.  Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.

Authors:  M Starec; B Rouveix; M Sinet; F Chau; B Desforges; J J Pocidalo; P Lechat
Journal:  J Pharmacol Exp Ther       Date:  1991-11       Impact factor: 4.030

2.  Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

Review 3.  Transfusion-related immunomodulation (TRIM): an update.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Blood Rev       Date:  2007-09-04       Impact factor: 8.250

4.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine.

Authors:  P Di Francesco; R Gaziano; I A Casalinuovo; A T Palamara; C Favalli; E Garaci
Journal:  Chemotherapy       Date:  1997 May-Jun       Impact factor: 2.544

6.  Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.

Authors:  A A Weinbroum; P Halpern; V Rudick; P Sorkine; M Freedman; E Geller
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

7.  Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis.

Authors:  Elisabet Reyes-Irisarri; Antonio J Sánchez; Juan Antonio García-Merino; Guadalupe Mengod
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

8.  Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey.

Authors:  J H Hansen-Flaschen; S Brazinsky; C Basile; P N Lanken
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

9.  The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

10.  Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.

Authors:  Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

View more
  5 in total

1.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

2.  Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Robert D Sanders; Timothy D Girard; Stuart McGrane; Jennifer L Thompson; Ayumi K Shintani; Daniel L Herr; Mervyn Maze; E Wesley Ely
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

3.  Sedation improves early outcome in severely septic Sprague Dawley rats.

Authors:  Hong Qiao; Robert D Sanders; Daqing Ma; Xinmin Wu; Mervyn Maze
Journal:  Crit Care       Date:  2009-08-19       Impact factor: 9.097

4.  Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study.

Authors:  Saad Nseir; Jérémy Hoel; Guillaume Grailles; Aude Soury-Lavergne; Christophe Di Pompeo; Daniel Mathieu; Alain Durocher
Journal:  Crit Care       Date:  2009-04-21       Impact factor: 9.097

5.  Protocol for a multicentre, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients: the ED-SED Study.

Authors:  Brian M Fuller; Nicholas M Mohr; Brian W Roberts; Christopher R Carpenter; Marin H Kollef; Michael S Avidan
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.